International Journal of Technology Assessment in Health Care

Article	Citations
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders – Erratum	154
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	24
PP296 Patient Involvement In An Assessment Of The Management Of Sudden Onset Severe Headache Presenting To The Emergency Department	16
PP428 Rechargeable Versus Recharge-Free Sacral Neurostimulation: An Australian Health Economics Analysis	16
PP254 Double-Counting In Evidence Synthesis Including Routinely Collected Data: Methodological and Practical Considerations	15
PP89 The Investigation And Development Of A National Formulary Monitoring System Across Wales	15
PP230 Safety, Effectiveness, And Cost Effectiveness Of Interventions For Preventing Delirium In Hospitalized Patients	15
PP451 Does NICE Reimburse Oncology Treatments Meeting End-Of-Life Criteria More Often Than Treatments That Do Not?	15
PP231 Safety, Effectiveness And Economic Analysis Of Exercise Intervention For Prevention Of Cognitive And Functional Deterioration In Hospitalized Patients	14
PP403 New Medical Technology Adoption In Asia Pacific: Focused On South Korea And Japan	13
PP299 A Framework And Analysis Assessing The Impact Of Patient-Centered Outcome Evidence In HTA Appraisals	13
PP447 Informing The Development And Evaluation Of An Evidence-Based Service Delivery Model For Mental Health Patients With Complex Needs	13
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder	12
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”	12
PP106 Twenty Years Of Orphan Medicines Regulation: Have Treatments Reached Patients In Need Across Europe And Canada?	10
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities – Erratum	9
PP216 Indirect Treatment Comparison Assessment: An Improvement Intervention In The Scottish Medicines Consortium	9
OP318 Health Technology Assessment And Decision-Making Processes: The Purchase Of Magnetic Resonance Imaging Technology	9
The transcatheter aortic valve implantation: an assessment of the generalizability of the economic evidences following a systematic review	8
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury	8
Addressing uncertainty in relative effectiveness assessments by HTA organizations	8
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses	7
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation	7
Methods and criteria for the assessment of orphan drugs: a scoping review	7
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands	7

OP107 Streamlining Health Technology Assessment Of Medical Devices Through Development Of The Philippine Essential Medical Device List	7
OP05 The Role Of Conditional Reimbursement In The Lifecycle Approach	7
PP83 Economic Impact Of Missed Vaccinations On The Italian National Health System	7
OP37 Lifecycle Evaluation Models And Frameworks Used To Assess Medical Devices: A Qualitative Evidence Synthesis	6
PP72 SARS-CoV-2: A Rapid Review On The Effectiveness Of Face Coverings To Reduce Transmission	6
PP107 Scale For Measuring Fatigue In Patients With Parkinson’s Disease: Scientific Technical Report	6
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management	5
OP49 A Systematic Review Of The Activities Of Early Advice, Early Dialogue, Scientific Advice By HTA Doers	5
PP21 Efficacy And Safety Of Aromatherapy: An Overview Of Systematic Reviews	5
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis	5
PD44 Realistic Review: Theoretical Model For Monitoring And Evaluation (M&E) Of Health Technology Assessment Management	4
OP46 Assessing The Quality Of Pharmacoeconomic Evaluations About Type 2 Diabetes Mellitus Drugs In National Reimbursement Drug List	4
PP49 Financing The Line Of Care In The First Biochemical Relapse Of Prostate Cancer After [68Ga] PSMA PET- CT	4
OP71 PriTec Tool 2: Adaptation For Selection Of Technologies To Be Assessed For Inclusion Into The Health Care System	4
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective	4
PP91 Developing A Re-assessment Process For Non-medicine Health Technologies In Wales	4
OP80 ‘Green Metrics’ - Incorporating Environmental Dimensions In Health Technology Assessment	4
PP71 Lessons Learned During Analyses Of Appropriate Hearing Care: Building Bridges Between Patient Organizations, Health Professionals And Insurance Companies	4
THC volume 38 issue S1 Cover and Front matter	4
PP32 Assessment Of Preferences For Treatment: A Discrete Choice Experiment Among Italian Patients With Prostate Cancer	4
OP06 Percutaneous Transforaminal Endoscopic Discectomy: From Insufficient Evidence To Reimbursement	4
PD03 Uptake Of Health Technology Assessment In Hospitals: A Scoping Review	4
PP48 A Micro-Costing Study For Circulating Tumor DNA testing In Oncology	4
OP20 Is The Quality Of Evidence In Health Technology Assessment Deteriorating Over Time?: A Case Study On Cancer Drugs In Australia	4
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service	4
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis	4
PP128 Development And Piloting Of An Online Training Course On Health Technology Assessment For Patients	4
OP84 Cost Consequence Analysis: A Potential Framework To Incorporate Patient Preferences Into Health Technology Assessment And Reimbursement Decisions	4
PP77 Safety, Effectiveness, And Cost Effectiveness Of Telemedicine In Neurological Diseases	4
OP15 Improving The Osteoporosis Care Trajectory By Collaboration Between Clinicians, Patients And Health Insurers Within the Appropriate Care Program	3
PD12 Quality Assessment Of Health Economic Evaluation On Screening Programs From China	3
PD34 Neuron-specific Biomarkers Associated With Neurological Manifestations In COVID-19: An Evidence Mapping Systematic Review	3
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets	3
THC volume 38 issue S1 Cover and Back matter	3
OP74 Assessing Public Confidence Towards COVID-19 Vaccines Through Social Media Insights Leveraged Using Artificial Intelligence Techniques	3
PP81 Barriers To Implementation Of Health Technology Assessment	3
PP140 Economic Evaluation Of Several Vaccination Strategies Against Rotavirus In Spain	3
PP69 Supporting Decision Making: A Health Technology Assessment Training Proposal for Decision Makers	3
PD38 Telehealth Use To Fight The COVID-19 Pandemic In A Brazilian Private Healthcare System	3
PP37 A Systematic Review of Machine Learning and Statistical Models For Predicting Coronary Heart Disease In Diabetic Patients	3
PP10 Impact Of COVID-19 On The Management Of Breast Cancer In Italy: The Perspectives Of Patients And Coordinators	3
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries	3
PD48 Does Unmet Need Influence The Scottish Medicines Consortium Health Technology Assessment Decisions For Rare Disease Conditions?	3
PP85 The Cost-Effectiveness Of The Anti-COVID Vaccination Campaign In The Italian Healthcare Setting	3
OP88 Drawing Lines In The Sand: How Do We Define The Scope Of Analysis In HTA And Economic Evaluation?	3
PP146 The Use Of Indirect Comparisons For Reimbursement Decision Making In The Netherlands And England	3
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy	3
Medicine characteristics affecting the time to guidance publication by National Institute for Health and Care Excellence in the single technology appraisal process	2
OP12 Post-Launch Evidence Generation Among Health Technology Assessment Bodies In Europe	2
PP55 Citizens’ General Needs Assessment In SOTERIA Project: ‘User-friendly Digital Secured Personal Data And Privacy Platform’	2

PP26 Critical Review Of The Reimbursement Process For Software As A Medical Device And Challenges In South Korea	2
PP49 Cost Of Cardiac Implantable Electronic Device (CIED) Infections In Australia: A Private And Public Sector Payer Perspective	2
OP127 The Cost Effectiveness Of Anti-Vascular Endothelial Growth Factor Treatments For Age-Related Macular Degeneration In The Italian Healthcare Setting	2
PP138 Awareness Of Health Technology Assessment And Its Predictors Among Medical Students In Public Universities In Klang Valley, Malaysia	2
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 1	2
Early technology review: towards an expedited pathway	2
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”	2
PP71 Hospitalization Costs Associated With Advanced Non-Small Cell Lung Cancer In China: Real World Evidence From Jiangsu	2
Evidence-Informed Update of Argentina’s Health Benefit Package: Application of a Rapid Review Methodology	2
PP122 The Feasibility Assessment For Domestic Introduction Of Newborn Pulse Oximetry Screening For Critical Congenital Heart Disease	2
PP52 Will Joint European Health Technology Assessment Provide Additional Benefits Over Individual Country-wise Assessments?	2
Acknowledgements	2
OP90 Multiple Myeloma: Developing A Benchmark Patient Experience Index In Australia And New Zealand	2
PP14 The Role Of Health Technology Assessment In The Public Hospitals Of The National Health Service Of Catalonia	2
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation	2
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride	2
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	2
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations	2
OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation	2
OP100 Patient Perspectives In Value Assessment Frameworks: The Asia Pacific Perspective	2
OP01 Causal Association Between Type 2 Diabetes Mellitus And Risk Of Cancer	2
OP165 Changing Decision Criteria: An Analysis Of Health Technology Assessment Reports To The Brazilian Unified Health System	2
PP127 Early Health Technology Assessment (HTA) Of Medical Technologies To Inform Subsidy Decision-making In Singapore	2
PP41 Using Medicare Claims Data To Support Reimbursement Of A Novel Leadless Pacing System For The Management Of Bradycardia	2
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases	2
OP07 Eleven Years Of Conitec: Advances And Challenges Of Patient And Public Involvement In The Brazilian Health Technology Assessment Process	1
PP92 Enhancing Patient Engagement In Health Technology Assessment: Identification Of Barriers, Facilitators, And Proposals For Improvement	1
OP94 Economic Evidence On Hemodialysis Access Creation Procedures In Patients With End-Stage Kidney Disease: A Systematic Literature Review	1
PP36 Real-world Effectiveness Of Umeclidinium And Umeclidinium/Vilanterol For Chronic Obstructive Pulmonary Disease: A Singapore Database Study	1
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation	1
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement	1
Evidence of clinical benefit of cancer medicines considered for funding in Australia	1
Development, testing, and implementation of a new procedure to assess the clinical added benefit of pharmaceuticals	1
Stakeholder preferences for attributes of digital health technologies to consider in health service funding	1
PP50 Early Diagnosis Effect Of Newborns With Critical Congenital Heart Disease Using National Health Insurance Data In South Korea	1
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations	1
PP103 Budget Impact Analysis Of Utilization Of WavelinQ Endo-arteriovenous Fistula System For Hemodialysis Patients: An Australian Hospital Perspective	1
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future	1
OP70 Treating Patients With Hormone-Sensitive Cancer On Endocrine Therapy With Denosumab (Prolia®): A Systematic Review And Network Meta-Analysis	1
PP99 Positron Emission Tomography Combined With Computed Tomography (PET/CT) Using 11-C Methionine (11C-MET)	1
Moving from intervention management to disease management: a qualitative study exploring a systems approach to health technology assessment in Canada	1
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation	1
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment	1
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	1
PP28 Is My Medicine Suitable For An Outcomes Based Agreement? The Feasibility Conundrum	1
OP115 Scoping Meta-Review On Methods Used To Assess Artificial Intelligence-Based Medical Devices For Heart Failure	1
PD141 Health Technology Assessment Methodology Approach For Precision Personalized Medicine: An Innovative Public Procurement Case Study	1
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study	1
OD45 Evaluating Quality In Health Economics: Quality Appraisal Checklist For Systematic Reviews Of Studies Eliciting Health State Utility Values	1
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum	1
OP149 How To Improve The Impact Of Health Technology Assessment: Stakeholders’ Perspectives In Spain	1
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples	1
A decision-support tool for funding health innovations at a tertiary academic medical center	1
Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease	1
OP14 Cost-Utility Analysis Of Regorafenib For Patients With Hepatocellular Carcinoma Who Progressed On Sorafenib Treatment	1
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	1
PP38 Immersion in water during childbirth: A survey to the Spanish National Health System	1
PP124 Patisiran For Patients With Hereditary Transthyretin Amyloidosis (hATTR) With Stage 2 Polyneuropathy Or Who Have An Inadequate Response To Tafamidis	1
Assessing progression of health technology assessment implementation in Asia: a balanced scorecard for cross comparison of selected countries in Asia	1
PP13 Results Of An International Survey About Barriers In Patient Involvement In Health Technology Assessment Of Digital Health Technologies	1
Can knowledgeable experts assess costs and outcomes as if they were ignorant? An experiment within precision medicine evaluation	1
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture	1
Mapping frameworks for synthesizing qualitative evidence in health technology assessment	1
Health technology assessment and innovation: here to help or hinder?	1
PP102 Sustaining Ghana’s National Health Insurance Scheme: Leveraging The Role Of Priority-Setting Tools In Benefit Package Reviews	1
PP90 Artificial Intelligence To Detect Ischemic Heart Disease In Non-traumatic Chest Pain At The Emergency Department – SmartHeart Study	1
PP26 Systematic Literature Review Of Funding Models For The Access To Drugs For Patients With Rare Diseases	1
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization	1
PD202 Reimbursement Success For Pharmaceutical Products With Noncomparative Data: Are Health Technology Assessment Bodies Well Suited To Embrace Innovations?	1
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report	1
In Memoriam: H. David Banta	1
PD140 A Strengths, Weaknesses, Opportunities, And Threats Analysis Of Prehabilitation Before Elective Surgery For Frail Elderly Patients	1
OP52 Treating Osteoporosis In Postmenopausal Women With Denosumab (Prolia®): A Systematic Review And Network Meta-Analysis	1
PD26 Overscreening For Older Women In Cervical And Breast Cancer Screening In Japan	1
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease	1
Stakeholder perspectives on the current status and potential barriers of patient involvement in health technology assessment (HTA) across Europe	1
OP93 The Cost Effectiveness Of Antiretroviral Therapy Adherence Interventions In HIV/AIDS Patients: A Systematic Review Of Decision Analytic Models	1
OP08 International Benchmarking Of Health Technology Assessment Training Tools And Materials For Patients And Consumers	1
Deliberative processes in decision making informed by health technology assessment in Latin America	1
OP171 Canadian Disease Registry Inventory: Environmental Scan Of The Literature	1

Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3	1
OP130 Estimating The Economic Burden Of HIV/AIDS In Türkiye Towards The Next Decade	1
OP01 Convergent Validity Between Discrete Choice Experiment And Other Stated Preference Methods: A Multistudy Comparison	1
OP152 Use of Real-world Evidence By The Brazilian Health Technology Assessment Committee (Conitec) For Monitoring Of Health Technologies	0
PP59 Do Patient Contributions Matter? A Thematic Document Analysis Of NICE Ultra-Rare Disease Appraisals	0
Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting	0
PD205 “Medical Fund” – A Novel Approach To Granting Individuals Access To Cutting-Edge Therapies	0
OP97 Stakeholders’ Involvement In Brazilian Health Technology Assessment Incorporation In 2021: A Statistical Description Of Demands To The Brazilian National Committee For Health Technology Incorpora	0
OP74 Analysis Of Literature And Research Foci In Overdiagnosis Based On Citespace	0
PP95 Health Professionals’ Participation On Health Technology Assessment (HTA) Public Consultation: A Distribution Analysis Of Brazilian HTA In 2021	0
PP42 Impact Of The COVID-19 Pandemic On Scottish Medicine Consortium Submission Characteristics, Acceptance Rates, And Time To Advice	0
PD93 Uncertainty Metric To Guide PICOS Assessment And Evidence Synthesis Planning For Joint Clinical Assessment Submission	0
OP78 Taking A Societal Perspective In Health Technology Assessment: Is Environmental Impact A Special Case?	0
Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India	0
PD130 Health Technology Assessment Of Cervical Cancer Screening In Indonesia	0
OP67 Considerations Of Treatment Novelty In Health Technology Assessment	0
PP61 Plugging the Gap of Fetoscopy in Congenital Diaphragmatic Hernia Pregnancies: Value for Money?	0
Health technology assessment for oral health in the past decade: a scoping review	0
PD23 Economic Evaluation Of Prophylactic Immunoglobulin Versus Prophylactic Antibiotics In Hematological Malignancies: Results From The RATIONAL Feasibility Trial	0
OP27 Health Technology Assessment Processes, Characteristics, And Key Differences In High, Middle, And Low-Income Countries Of Asia Pacific Region	0
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions	0
PP62 Recommendations On Methodologies To Obtain Comparator Efficacy In Health Economic Assessments Of Tumor-Agnostic Drugs	0
OP38 Perinatal And Infant Mental Health Care: International Guideline Recommendations And Situation In Austria	0
PP57 Collaborating In Times Of COVID: The Launch Of The National Wales COVID-19 Evidence Centre	0
PP05 Effect Modifiers In Indirect Treatment Comparisons: Guidance Is Needed To Ensure An Unbiased Identification In Decision-Making	0
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review	0
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations	0
OP82 Patient Involvement In Health Technology Assessment	0
PP89 Stimulating And Assuring Evidence Quality From A Dutch Funders’ Perspective – Introducing The ZonMw Reporting Checklist	0
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	0
OP43 Incorporating Mathematical Modeling To Improve Accuracy Of Budget Impact Analysis: Using Screening For Hepatitis C As An Example	0
OP64 NICE Listens: Engaging The Public On How To Address Health Inequalities In Health Technology Assessment And Guideline Development	0
PP424 Piloting A Comprehensive Search For eHealth Definitions In The Grey Literature: Preliminary Results From A Systematic Scoping Review	0
PP32 Health Technology Assessment Regulation In Europe: Implications For A National Authority	0
Deliberative process of health technology reassessment by health technology assessment agency in Korea	0
OP63 A European Value Assessment Framework For Next-Generation Sequencing And Comprehensive Genomic Profiling Oncology Diagnostics	0
OP242 Patient-based Evidence: A Comparison Of The Views Of Patient And Clinical Engagement Participants And Committee Members	0
PD156 Scanning The Right Horizons: Does Singapore’s Horizon Scanning Identify And Assess The Relevant Technologies?	0
PP132 Health Technology Assessment Agencies’ Expectations Regarding Patient Experience Data in Australia, China, And Japan	0
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care	0
PP79 Use Of Vagus Nerve Stimulation Therapy In Treatment-Resistant Depression	0
PP27 The Private Healthcare Responses Against COVID-19 Emergencies In Brazil	0
PD216 Efficiency Frontier Analysis: Supporting Sustainable Non-Small Cell Lung Cancer Healthcare Policies In Brazil	0
PP115 Analysis Of Previous Joint Clinical Assessment And Potential Transferability To Four European Countries: Case Study And Conceptual Approach	0
OP02 The Use Of Discrete Choice Experiments For Measuring Patient Preferences In Health Technology Assessment	0
Preparing future doctors for evidence-based practice: a study on health technology assessment awareness and its predictors in Malaysia	0
PP88 Breaking Boundaries In Health Technology Assessment: Quantifying Non-Traditional Value Of Medical Technology Through ExpertLink Remote Connectivity Solutions	0
OP63 Incorporating Machine Learning Methods In Health Economic Evaluations: A Case Study On Depression Prevention	0
PP151 VALIDATE Methodology On A Medication-Related Clinical Decision Support System: Holistic Assessment For Optimal Technology Adoption	0
Implementation of the EU’s Health Technology Assessment regulation: where does existing methods guidance require concretization and what are the relevant methodological options?	0
PP76 “It Is Better For Me To Die Than To Be Disgraced”: Perceptions Of Worse-Than-Death Health States In Ghana	0
PP142 Time-Driven Activity-Based Costing (TDABC) Of Brazilian Public Healthcare System (SUS): Preliminary Results For Osteogenesis Imperfecta (OI)	0
OP34 Application Of A Case-Mix Analysis In COVID-19 Management At A University Hospital In Malaysia	0
PP66 Safety, Effectiveness And Cost-effectiveness Of Scalp Cooling Devices For The Prevention Of Chemotherapy-induced Alopecia	0
PD204 Comparison Of Reimbursement Systems In France Denmark, Norway, And The United Kingdom - Possibilities Of Implementation In Poland	0
PD56 Conceptual Issues In The Valuation Of Health States In Children	0
PP110 An External Combined Occipital And Trigeminal Neurostimulation Device For Migraine Treatment	0
PD27 The Cost Effectiveness Of Non-Hospital Cardiac Rehabilitation: A Systematic Review	0
PP129 Usefulness, Acceptability And Satisfaction Of A Decision Making Tool For Clinical Meso-Management In Type 2 Diabetes Mellitus	0
PP90 Effectiveness Of Music Therapy For Autism Spectrum Disorder, Dementia, Depression, Insomnia, And Schizophrenia	0
PD08 A Systematic Review Of Reporting Quality Of Economic Evaluations In TCM In NRDL Of China Based On CHEERS	0
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	0
PP83 Building Resilient Capacity For The Diagnosis Of Cardiac Pathologies Through Telemedicine: Pilot Study	0
Experiences of patient organizations’ involvement in medicine appraisal and reimbursement processes in Finland – a qualitative study	0
OD15 Multiparametric Magnetic Resonance Imaging In Biopsy-Naive Patients: A Real-World Evidence For Decision-Making In Prostate Cancer Pathway	0
Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body	0
PD224 Evaluating Participant Satisfaction In Health Technology Assessment Reports: A Survey Study In Catalonia, Spain	0
PP167 Cost Effectiveness Of Universal Childhood Vaccination Against Hepatitis A	0
OP129 A Cost-Utility Analysis Of Denosumab (Prolia®) For Treating Osteoporosis In Postmenopausal Women: A Swiss Healthcare Payer Perspective	0
PP96 Joint Clinical Assessments – Implementation And Lessons For The Next Stage Of EU HTA	0
PD21 Data Sources And Real-World Data On Medical Devices In The Brazilian Scenario	0
PD171 National Health Service Wales - First UK Nation To Approve Dostarlimab For The Treatment Of Rectal Cancer	0
PP112 Reimbursement Decisions for Medical Services in Austria: An Analysis of Influencing Factors for the Hospital Individual Services Catalogue	0
PD02 A Literature Review Of Treatment Schemes And Effects For Beta Thalassemia In China	0
PD83 Medication Preferences Of Rural Patients With Chronic Disease: A Discrete Choice Experiment In An Eastern Province Of China	0
PP117 Larger Impact Of An Appropriate Care Program By Involving Healthcare Professionals: A Case Report On Cervical Pre-malignancy	0
PD54 Burden Of Disease And Risk Factors Among Children Under 5 Years In China From 1990 To 2019	0
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	0
OP10 Affordability Decision Rules: Systematic Review And Categorization Of Budget Impact Thresholds For 174 Countries Based On International Practices	0
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain	0
PP17 Is the PriTec Tool Useful In The Identification Of Disruptive Healthcare Technologies?	0
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of “Failed” R&D Efforts	0
PD222 Balancing Patient Preferences With Feasible Healthcare Delivery: Using Discrete Choice Experiments Alongside Knowledge Exchange To Inform Care Pathways	0
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group	0
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience	0
PP100 Improving The Assessment Of Effectiveness For Digital Applications Using The B Statistic: Using WtsWrng As A Case Study	0
PP74 Are Commonly Used Cost-Effectiveness Thresholds Too Low? Empirical Evidence From Economic Studies On The Value Of Life	0
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil	0
PD25 Use Of Real-World Evidence In The Reimbursement Assessment Of Medical Devices	0
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device	0
Scaling up health technology assessment capacities in selected African countries – A conceivable route ahead	0
PD70 A Mapping Study Of EORTC-QLQ-C30 To EQ-5D-5L Among Korean Patients With Non-Small Cell Lung Cancer	0
PD13 Methodologies In Economic Evaluations Of Biomarkers – A Systematic Review	0
PD45 Paying For Digital Health: What Evidence Is Needed?	0
PD209 Social Burden Of Inflammatory Bowel Diseases In Poland: Impact Of Changes In Drug Programs On Social Security Expenditures	0